TY - JOUR
T1 - Practical guidelines on endoscopic treatment for Crohn's disease strictures
T2 - a consensus statement from the Global Interventional Inflammatory Bowel Disease Group
AU - Shen, Bo
AU - Kochhar, Gursimran
AU - Navaneethan, Udayakumar
AU - Farraye, Francis A.
AU - Schwartz, David A.
AU - Iacucci, Marietta
AU - Bernstein, Charles N.
AU - Dryden, Gerald
AU - Cross, Raymond
AU - Bruining, David H.
AU - Kobayashi, Taku
AU - Lukas, Martin
AU - Shergill, Amandeep
AU - Bortlik, Martin
AU - Lan, Nan
AU - Lukas, Milan
AU - Tang, Shou Jiang
AU - Kotze, Paulo Gustavo
AU - Kiran, Ravi P.
AU - Dulai, Parambir S.
AU - El-Hachem, Sandra
AU - Coelho-Prabhu, Nayantara
AU - Thakkar, Shyam
AU - Mao, Ren
AU - Chen, Guodong
AU - Zhang, Shengyu
AU - Suárez, Begoña González
AU - Lama, Yago Gonzalez
AU - Silverberg, Mark S.
AU - Sandborn, William J.
N1 - Funding Information:
DHB and WJS have received partial funding from the US National Institutes of Health. The consensus process, which included the development of the consensus statements, attendance of face-to-face meetings and voting, and electronic voting of revised consensus statements, was largely self-funded, with participants devoting their own free time and effort. In addition, the development, writing, and final approval of the manuscript were largely self-funded. Unrestricted grants (less than US$10 000 in value) were provided by Boston Scientific and OVESCO for the meeting space.
Funding Information:
DHB and WJS have received partial funding from the US National Institutes of Health. The consensus process, which included the development of the consensus statements, attendance of face-to-face meetings and voting, and electronic voting of revised consensus statements, was largely self-funded, with participants devoting their own free time and effort. In addition, the development, writing, and final approval of the manuscript were largely self-funded. Unrestricted grants (less than US$10 000 in value) were provided by Boston Scientific and OVESCO for the meeting space.
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/4
Y1 - 2020/4
N2 - Stricture formation is a common complication of Crohn's disease, resulting from the disease process, surgery, or drugs. Endoscopic balloon dilation has an important role in the management of strictures, with emerging techniques, such as endoscopic electroincision and stenting, showing promising results. The underlying disease process, altered bowel anatomy from disease or surgery, and concurrent use of immunosuppressive drugs can make endoscopic procedures more challenging. There is an urgent need for the standardisation of endoscopic procedures and peri-procedural management strategies. On the basis of an extensive literature review and the clinical experience of the consensus group, which consisted of representatives from the Interventional Inflammatory Bowel Disease Group, we propose detailed guidance on all aspects of the principles and techniques for endoscopic procedures in the treatment of inflammatory bowel disease-associated strictures.
AB - Stricture formation is a common complication of Crohn's disease, resulting from the disease process, surgery, or drugs. Endoscopic balloon dilation has an important role in the management of strictures, with emerging techniques, such as endoscopic electroincision and stenting, showing promising results. The underlying disease process, altered bowel anatomy from disease or surgery, and concurrent use of immunosuppressive drugs can make endoscopic procedures more challenging. There is an urgent need for the standardisation of endoscopic procedures and peri-procedural management strategies. On the basis of an extensive literature review and the clinical experience of the consensus group, which consisted of representatives from the Interventional Inflammatory Bowel Disease Group, we propose detailed guidance on all aspects of the principles and techniques for endoscopic procedures in the treatment of inflammatory bowel disease-associated strictures.
UR - http://www.scopus.com/inward/record.url?scp=85081266504&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081266504&partnerID=8YFLogxK
U2 - 10.1016/S2468-1253(19)30366-8
DO - 10.1016/S2468-1253(19)30366-8
M3 - Review article
C2 - 31954438
AN - SCOPUS:85081266504
SN - 2468-1253
VL - 5
SP - 393
EP - 405
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
IS - 4
ER -